James Geraghty is currently an Entrepreneur in Residence at Third Rock Ventures in Boston and Chairman of Idera Pharmaceuticals (NASDAQ: IDRA). Prior to Third Rock Ventures, Mr. Geraghty served as Senior Vice President, North America strategy and business development, at Sanofi. Before Sanofi, he spent 20 years at Genzyme Corporation, most recently as Senior Vice President and an Officer. While at Genzyme, his roles included, President of Genzyme Europe and General Manager of Genzyme's cardiovascular business. He also led strategic transactions that brought important new products into Genzyme. He served as a director of GTC Biotherapeutics (formerly Genzyme Transgenics Corporation), where he was Chairman, President and CEO. Mr. Geraghty also oversaw Genzyme's Humanitarian Assistance for Neglected Diseases program, under which Genzyme helped develop innovative therapeutic programs on a non-commercial basis. He served as co-chair of the executive committee for BIO 2007. A graduate of the Yale Law School, he has published articles in the Yale Law Journal, Health Affairs, and other publications. Mr. Geraghty holds an MS from the University of Pennsylvania and a BA from Georgetown University.
Chairman of the Board
Entrepreneur in Residence, Third Rock Ventures